Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children

被引:0
|
作者
Files, Megan A. [1 ]
Gentles, Lauren [2 ]
Kehoe, Leanne [3 ]
Adler, Amanda [3 ]
Lacombe, Kirsten [3 ]
Dickerson, Jane A. [4 ,5 ]
Greninger, Alexander [4 ]
Waghmare, Alpana [6 ,7 ,8 ]
Fairlie, Tarayn [9 ]
Pringle, Kimberly [9 ]
Midgley, Claire M. [9 ]
Hagen, Melissa Briggs [9 ]
Englund, Janet A. [3 ,6 ,8 ]
Seshadri, Chetan [1 ]
机构
[1] Univ Washington, Sch Med, Dept Med, 750 Republican St,Suite E663, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Ctr, Div Basic Sci, Seattle, WA USA
[3] Seattle Childrens Res Inst, Div Pediat Infect Dis, MA 7-234,4800 Sand Point Way NE, Seattle, WA 98105 USA
[4] Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA USA
[5] Seattle Childrens Hosp, Dept Labs, Seattle, WA USA
[6] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[7] Seattle Childrens Hosp, Ctr Clin & Translat Res, Seattle, WA USA
[8] Univ Washington, Dept Pediat, Seattle, WA USA
[9] Ctr Dis Control & Prevent, Coronavirus & Other Resp Viruses Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2024年 / 230卷 / 04期
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
children; COVID-19; SARS-COV-2 nucleocapsid antibody; SARS-COV-2 spike antibody; T-cell immunity to SARS-CoV-2;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The kinetics and durability of T-cell responses to SARS-CoV-2 in children are not well characterized. We studied a cohort of children aged 6 months to 20 years with COVID-19 in whom peripheral blood mononuclear cells and sera were archived at approximately 1, 6, and 12 months after symptom onset. Methods. We compared antibody responses (n = 85) and T-cell responses (n = 30) to nucleocapsid (N) and spike (S) glycoprotein over time across 4 age strata: 6 months to 5 years and 5-9, 10-14, and 15-20 years. Results. N-specific antibody responses declined over time, becoming undetectable in 26 (81%) of 32 children by approximately 1 year postinfection. Functional breadth of anti-N CD4+ T-cell responses also declined over time and were positively correlated with N-antibody responses (Pearson r = .31, P = .008). CD4+ T-cell responses to S displayed greater functional breadth than N in unvaccinated children and, with neutralization titers, were stable over time and similar across age strata. Functional profiles of CD4+ T-cell responses against S were not significantly modulated by vaccination. Conclusions. Our data reveal durable age-independent T-cell immunity to SARS-CoV-2 structural proteins in children over time following COVID-19 infection as well as S-antibody responses in comparison with declining antibody responses to N.
引用
收藏
页码:889 / 900
页数:12
相关论文
共 50 条
  • [1] Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children
    Files, Megan A.
    Gentles, Lauren
    Kehoe, Leanne
    Adler, Amanda
    Lacombe, Kirsten
    Dickerson, Jane A.
    Greninger, Alexander
    Waghmare, Alpana
    Fairlie, Tarayn
    Pringle, Kimberly
    Midgley, Claire M.
    Hagen, Melissa Briggs
    Englund, Janet A.
    Seshadri, Chetan
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (04): : 889 - 900
  • [2] Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients
    How, Joan
    Gallagher, Kathleen M. E.
    Liu, Yiwen
    Katsis, Katelin
    Elder, Eva L.
    Larson, Rebecca C.
    Leick, Mark B.
    Neuberg, Donna
    Maus, Marcela V.
    Hobbs, Gabriela S.
    LEUKEMIA, 2022, 36 (04) : 1176 - 1179
  • [3] Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients
    Joan How
    Kathleen M. E. Gallagher
    Yiwen Liu
    Katelin Katsis
    Eva L. Elder
    Rebecca C. Larson
    Mark B. Leick
    Donna Neuberg
    Marcela V. Maus
    Gabriela S. Hobbs
    Leukemia, 2022, 36 : 1176 - 1179
  • [4] Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency
    Hannah Kinoshita
    Jessica Durkee-Shock
    Mariah Jensen-Wachspress
    Vaishnavi V. Kankate
    Haili Lang
    Christopher A. Lazarski
    Anjeni Keswani
    Kathleen C. Webber
    Kimberly Montgomery-Recht
    Magdalena Walkiewicz
    Luigi D. Notarangelo
    Peter D. Burbelo
    Ivan Fuss
    Jeffrey I. Cohen
    Catherine M. Bollard
    Michael D. Keller
    Journal of Clinical Immunology, 2021, 41 : 1146 - 1153
  • [5] T-cell responses and therapies against SARS-CoV-2 infection
    Toor, Salman M.
    Saleh, Reem
    Sasidharan Nair, Varun
    Taha, Rowaida Z.
    Elkord, Eyad
    IMMUNOLOGY, 2021, 162 (01) : 30 - 43
  • [6] T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
    Notarbartolo, Samuele
    VACCINES, 2024, 12 (10)
  • [7] Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency
    Kinoshita, Hannah
    Durkee-Shock, Jessica
    Jensen-Wachspress, Mariah
    Kankate, Vaishnavi V.
    Lang, Haili
    Lazarski, Christopher A.
    Keswani, Anjeni
    Webber, Kathleen C.
    Montgomery-Recht, Kimberly
    Walkiewicz, Magdalena
    Notarangelo, Luigi D.
    Burbelo, Peter D.
    Fuss, Ivan
    Cohen, Jeffrey I.
    Bollard, Catherine M.
    Keller, Michael D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1146 - 1153
  • [8] T Cell Responses to SARS-CoV-2
    Sette, Alessandro
    Sidney, John
    Crotty, Shane
    ANNUAL REVIEW OF IMMUNOLOGY, 2023, 41 : 343 - 373
  • [9] Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
    Tan, Yun
    Liu, Feng
    Xu, Xiaoguang
    Ling, Yun
    Huang, Weijin
    Zhu, Zhaoqin
    Guo, Mingquan
    Lin, Yixiao
    Fu, Ziyu
    Liang, Dongguo
    Zhang, Tengfei
    Fan, Jian
    Xu, Miao
    Lu, Hongzhou
    Chen, Saijuan
    FRONTIERS OF MEDICINE, 2020, 14 (06) : 746 - 751
  • [10] Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
    Yun Tan
    Feng Liu
    Xiaoguang Xu
    Yun Ling
    Weijin Huang
    Zhaoqin Zhu
    Mingquan Guo
    Yixiao Lin
    Ziyu Fu
    Dongguo Liang
    Tengfei Zhang
    Jian Fan
    Miao Xu
    Hongzhou Lu
    Saijuan Chen
    Frontiers of Medicine, 2020, 14 : 746 - 751